🇺🇸 FDA
Pipeline program

autologous skin fibroblasts

NA_00068684

Phase 2 mab active

Quick answer

autologous skin fibroblasts for Wounds and Injuries is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Wounds and Injuries
Phase
Phase 2
Modality
mab
Status
active

Clinical trials